Cardiff (NASDAQ: CRDF) Confirms Efficacy Of Onvansertib In Colorectal Cancer
Hasnain R
September 18, 2020
Shares of Cardiff Oncology, Inc. (NASDAQ: CRDF) were traded up 39.59% after it announced that Onvansertib has shown the clinical benefit in colorectal cancer. The